CEBIOTEX
Live / Registered — Registered (as of 25 Jun 2024)
What this means for you
Registered since 25 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79355286
- Registration number
- 7423781
- Mark type
- Design + words
- Filed
- 29 Sept 2022
- Published for opposition
- 09 Apr 2024
- Registered
- 25 Jun 2024
- Attorney of record
- Justin R. Young
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents for administering pharmaceuticals in the form of films which facilitate administration of pharmaceutical products; biopharmaceuticals for cancer treatment; drug delivery compounds that facilitate the delivery of pharmaceuticals; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating cancer; pharmaceutical preparations for oncological use; pharmaceutical preparations and substances for use in oncology; Veterinary products and substances for facilitating the delivery of pharmaceutical preparations; where all aforementioned goods exclude eye drops and pomades for ophthalmic or otorhinolaryngology use
- Class 007 — Machines and machine tools: 3D printers; 3D bioprinters; three-dimensional (3D) living tissue manufacturing machines in the nature of 3D printers; machines for manufacturing medical and veterinary drugs, implants, and preparations
- Class 042 — Scientific and technological services: Bacteriological research and consultancy; consultancy relating to research and development in the field of therapeutic drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; design of diagnostic apparatus and equipment; biotechnological research; scientific research for medical purposes in oncology; scientific research relating to chemistry; research regarding pharmaceutical products; medical research; stem cell research; biochemical research and analysis; research and development of products; conducting clinical trials for pharmaceutical products for others; scientific laboratory services; information and data systems design in the field of medical and veterinary research and development; pharmaceutical and medical research services; biomedical research services; research and development services in bacteriology; provision of medical and scientific research information regarding results of clinical trials relating to pharmaceutical products; information, advisory and consultancy services in relation to the aforesaid services
Owner
- CEBIOTEX, S.L., ES
- CEBIOTEX, S.L., ES
- CEBIOTEX, S.L., ES
Prosecution history
- 21 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Dec 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Dec 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 09 Dec 2024 — FINAL DISPOSITION PROCESSED
- 25 Sept 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 25 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 17 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 15 Apr 2024 — NOTIFICATION PROCESSED BY IB
- 09 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Apr 2024 — PUBLISHED FOR OPPOSITION
- 27 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Mar 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB